ORIC Insider Trading Activity and SEC Form 4 Filings
ORIC insider trading summary
Over the past 12 months, insiders at Oric Pharmaceuticals, Inc. (ORIC) reported 13 sales worth $2.1M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.1M.
Latest ORIC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Dominic Piscitelli | Chief Financial Officer | Sell | $189K (14,000 @ $13.53) |
| Oct 1, 2026 | Richard A. Heyman | Insider | Sell | $41K (3,200 @ $12.91) |
| Oct 1, 2026 | Richard A. Heyman | Insider | Sell | $45K (3,500 @ $12.91) |
| Sep 28, 2026 | Dominic Piscitelli | Chief Financial Officer | Sell | $181K (13,400 @ $13.53) |
| Sep 24, 2026 | Dominic Piscitelli | Chief Financial Officer | Sell | $7K (500 @ $13.51) |
| Sep 24, 2026 | Dominic Piscitelli | Chief Financial Officer | Sell | $1K (100 @ $13.50) |
| Aug 26, 2026 | Dominic Piscitelli | Chief Financial Officer | Sell | $1.1M (77,000 @ $13.69) |
| Jul 6, 2026 | Richard A. Heyman | Insider | Sell | $4K (300 @ $12.00) |
| Jan 16, 2026 | Richard A. Heyman | Insider | Sell | $38K (3,200 @ $12.00) |
| Jan 16, 2026 | Richard A. Heyman | Insider | Sell | $42K (3,500 @ $12.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.